Vimarsana
Biggest News Aggregation in the World

Lawson Macartney News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lawson Macartney. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lawson Macartney Today - Breaking & Trending Today

Viking Therapeutics (VKTX) Scheduled to Post Earnings on Wednesday - Vimarsana News

Viking Therapeutics (VKTX) Scheduled to Post Earnings on Wednesday

Viking Therapeutics (NASDAQ:VKTX – Get Free Report) is scheduled to release its earnings data after the market closes on Wednesday, July 26th. Analysts expect Viking Therapeutics to post earnings of ($0.21) per share for the quarter. Viking Therapeutics (NASDAQ:VKTX – Get Free Report) last issued its quarterly earnings data on Wednesday, April 26th. The biotechnology […]

Viking Therapeutics (NASDAQ:VKTX) Trading Up 3.7% - Vimarsana News

Viking Therapeutics (NASDAQ:VKTX) Trading Up 3.7%

Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Rating) rose 3.7% during mid-day trading on Wednesday . The company traded as high as $21.49 and last traded at $21.41. Approximately 793,171 shares were traded during mid-day trading, a decline of 78% from the average daily volume of 3,674,765 shares. The stock had previously closed at $20.64. Wall […]

Source: wkrb13.com
Viking Therapeutics, Inc. (NASDAQ:VKTX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - Vimarsana News

Viking Therapeutics, Inc. (NASDAQ:VKTX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Rating) has been assigned an average recommendation of “Moderate Buy” from the nine research firms that are currently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation and four have issued a buy recommendation on the company. The average twelve-month target price […]

Viking Therapeutics (NASDAQ:VKTX) Reaches New 12-Month High at $23.50 - Vimarsana News

Viking Therapeutics (NASDAQ:VKTX) Reaches New 12-Month High at $23.50

Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Rating) shares hit a new 52-week high during mid-day trading on Monday . The company traded as high as $23.50 and last traded at $22.46, with a volume of 338098 shares traded. The stock had previously closed at $22.86. Wall Street Analyst Weigh In VKTX has been the subject […]

Source: wkrb13.com
Viking Therapeutics (NASDAQ:VKTX) Hits New 52-Week High at $22.33 - Vimarsana News

Viking Therapeutics (NASDAQ:VKTX) Hits New 52-Week High at $22.33

Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Rating) shares hit a new 52-week high during trading on Monday . The company traded as high as $22.33 and last traded at $21.88, with a volume of 1212585 shares. The stock had previously closed at $21.31. Wall Street Analysts Forecast Growth VKTX has been the topic of a […]

Source: wkrb13.com